ACTA’s Board of Directors is responsible for the corporate governance and financial management of the organisation. Australian Clinical Trials Alliance Limited (ACN 168 693 972) is a not-for-profit public company limited by guarantee. ACTA’s Constitution can be viewed here.
ACTA Board Members
-
Prof Christopher Reid B.A, Dip Ed, M Sc, PhD
ACTA Board Chair
Research Professor at the School of Public Health and Preventive Medicine, Monash University and the School of Population Health at Curtin University
-
Prof Kate Lee BSc Mathematics, MSC Medical Statistics, PhD Medical Statistics
ACTA Board Director
-
Ms Anne McKenzie, AM
ACTA Board Director
Manager, Community Engagement, Telethon Kids Institute
-
Anita van der Meer M.Sc. MAICD
ACTA Board Director
Director Business Development, Health & Biosecurity – CSIRO
-
Prof Rachael Morton, DipAppSc, MSc(Clin Epi)(Hons), PhD
ACTA Board Director
Director, Health Economics, NHMRC Clinical Trials Centre, University of Sydney
-
Prof Trisha Peel – MBBS(Hons), GradCertClinRes, FRACP, PhD
ACTA Board Director
-
Mr Kieran Schneemann
ACTA Board Director
Director of Government Affairs, AstraZeneca. Associate Director for Canteen.
-
Prof Steve Webb MBBS MPH PhD FCICM FRACP FAHMS
ACTA Board Director
Intensive Care Unit, Royal Perth Hospital, School of Medicine & Pharmacology, University of Western Australia.
-
Ian A R Wilson FCPA, AGIA, ACIS, MAICD
ACTA Board Director
Grant Finance Office, The Florey Institute of Neuroscience & Mental Health
-
Prof Sophia Zoungas
ACTA Board Director
Head of the School of Public Health and Preventive Medicine (SPHPM) at Monash University
